Table 1.
Baseline characteristics of the study groups
| Baseline characteristics | Intranasal midazolam (n = 63) | Intranasal dexmedetomidine (n = 67) | Oral triclofos (n = 65) | p-value |
|---|---|---|---|---|
| Age (years), mean (SD) | 4.61 (3.07) | 4 (2.63) | 4.28 (2.91) | 0.93 |
| Male (n, %) | 35 (55.5%) | 42 (62.6%) | 36 (55.4%) | 0.84 |
| Weight (kg), mean (SD) | 17.01 (8.85) | 13.68 (5.92) | 14.31(6.18) | 0.19 |
| MRI done per group | ||||
| • MRI brain | 55 (87.3) | 56 (83.7) | 56 (86.1) | 0.57 |
| • MRI abdomen | 0 (0) | 1 (1.4) | 0 (0.0) | 0.34 |
| • MRI brain and spine | 3 (4.8) | 2 (2.9) | 2 (3.1) | 0.22 |
| • MRCP | 2 (3.2) | 3 (4.4) | 2 (3.1) | 0.86 |
| • MRI hand | 0 (0.0) | 1 (1.4) | 0 (0.0) | 0.49 |
| • MRI spine | 2 (3.2) | 3 (4.4) | 3 (4.6) | 0.27 |
| • MRI thigh | 1 (1.5) | 1 (1.4) | 2 (3.1) | 0.59 |
| Duration of MRI scan (min), mean (SD) | 37.7 (10.8) | 38.2 (10.7) | 37.9 (11) | 0.36 |
n = number
SD standard deviation, MRI magnetic resonance imaging, MRCP magnetic resonance cholangio-pancreatography